skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I'm currently invested in some "subscription model" Companies such as $APPL, $CRM, $MSFT, $AMZN.
Are there any other companies in Canada or the US that use a "subscription model" that you can recommend?

Thanks,

Valter
Read Answer Asked by Valter on August 27, 2018
Q: Good morning Team! I would like to thank you all for the amazing technical work that you do for me! I work full time and it would be impossible to spend the time required to research companies.(even though I would love to) Above is a portfolio that I started and I am wondering what you would suggest to add? Investment timeline 10+ yrs.
Read Answer Asked by Brad on August 10, 2018
Q: Good Morning,

My daughter's RESP has the following stocks. I have added some CSU because I simply can't pass up the buy opportunity on this weakness. I am overweight in IT now, what would you recommend for an 8 yr horizon please.

Current holdings:
BNS, CSU, DSG, DHX, ENB, ECI, HR.UN, KBL, MUX, RHT, STN, SLF, TSGI. She also has 3 ETF - US Dividend, Emerging Markets, Nasdaq Indexed all equal weight.

Thanks for all you do!!

Eric
Read Answer Asked by Erichsen on July 30, 2018
Q: Hello 5i team,

Today's Globe & Mail:
http://gold.globeinvestor.com/servlet/ArticleNews/story/RTGAM/20180531/ellipsis_OK5KOAGTGVAVZNM33Q4DTLYU4U/stocks/news

Two analysts re-rated Descartes Systems following release of 1st Qtr earning. One analyst (Laurentian Bank), re-rated the stock to "Hold from Buy" on valuation concerns and a slight miss on adjusted earning while all other metrics were higher than analysts' estimates, and then went on and commented on the company's strong potential growth going forward and increased his target to US $32.50. The other analyst (Canaccord), rated the stock a "Buy" and increased his target to US $35.00 from US $34.00. The analyst commented on the company's consistency, M&A activity providing the company's with faster growth segments with expected EBITDA growth of 15% suggesting the stock deserves a premium. Meanwhile the market reacted by selling down the stock with a mid-day drop of CAD $2.00. What gives? Please help me understand what drives markets in the short term and what is your recommendation on Descartes going forward.

Thank you!
Read Answer Asked by Joseph on June 01, 2018
Q: A recent article in the Globe was citing an RBC analyst as saying it was time to go underweight on tech stocks.
I have the following weightings in my portfolio -
ENGH - 6% ; SYZ, KXS and DSG 4% each.
Do you see any of these as being seriously overvalued? I have very good gains on all and have taken profits on all except KXS as they have moved up.
Any comments are appreciated.
Read Answer Asked by Robert on April 13, 2018
Q: Good day...I hold both kxs and dsg and other 5i tech stocks ...my overall tech allocation is 17%...my question is whether it makes sense to hold both kxs and dsg as their software tends to be similar but different ...could you please help me with this concern....Eugene
Read Answer Asked by gene on April 06, 2018
Q: Hello Peter, Ryan and Team,

Which 5 management teams are currently the best capital allocators in your view. I am guessing CSU would be up there. Who else?

Thank you,

Wes
Read Answer Asked by Wes on March 20, 2018
Q: Hi there,

Outside of your Balanced Equity Portfolio, what would be your top 5 ideas for growth today?

Thanks!
Read Answer Asked by Michael on March 12, 2018
Q: Hi Peter
RE: reducing weight in Financials and adjusting to non dividend companies.
I am very overweight in Financials and well balanced otherwise in other sectors except Gold and Energy. I would like to trim the former into opportunities for growth.
Can you suggest 3 companies that have been had some "correction" but remain good picks for future growth ? (prefer non-dividend)
Thanks,
Peter
Read Answer Asked by Linda on March 06, 2018
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!